What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Eleftherios P. Diamandis spends much of his time researching Kallikrein, Cancer, Internal medicine, Cancer research and Pathology.
Eleftherios P. Diamandis combines subjects such as Proteases and Molecular biology with his study of Kallikrein.
In his research on the topic of Cancer, Cancer biomarkers is strongly related with Biomarker.
He has included themes like Endocrinology and Oncology in his Internal medicine study.
Eleftherios P. Diamandis has researched Cancer research in several fields, including Ovarian cancer and Metastasis.
His work in Pathology covers topics such as Prostate-specific antigen which are related to areas like Antigen, Tumor marker and Urology.
His most cited work include:
- The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. (815 citations)
- Resveratrol: A molecule whose time has come? And gone? (719 citations)
- The biotin-(strept)avidin system: principles and applications in biotechnology. (629 citations)
What are the main themes of his work throughout his whole career to date?
Eleftherios P. Diamandis mainly investigates Internal medicine, Kallikrein, Cancer, Pathology and Cancer research.
His studies in Internal medicine integrate themes in fields like Endocrinology and Oncology.
His Kallikrein study incorporates themes from Proteases and Molecular biology.
His study in Cancer is interdisciplinary in nature, drawing from both Biomarker, Immunology and Bioinformatics.
His Bioinformatics research incorporates themes from Proteomics and Biomarker discovery.
His Cancer research research incorporates elements of KLK10 and Ovarian cancer.
He most often published in these fields:
- Internal medicine (43.34%)
- Kallikrein (37.09%)
- Cancer (38.76%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (43.34%)
- Cancer (38.76%)
- Disease (16.22%)
In recent papers he was focusing on the following fields of study:
Eleftherios P. Diamandis focuses on Internal medicine, Cancer, Disease, Oncology and Proteomics.
The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine.
His Cancer study combines topics from a wide range of disciplines, such as Cancer research, Blood test and Bioinformatics.
His Oncology study also includes fields such as
-
Prostate cancer which connect with Prostate,
-
Circulating tumor DNA which connect with Liquid biopsy.
His Proteomics research also works with subjects such as
-
Proteome which connect with Immunology and Inflammatory arthritis,
-
Proteases and related Kallikrein, Serine, Protease, Antimicrobial peptides and Female reproductive system.
Eleftherios P. Diamandis is interested in KLK6, which is a branch of Kallikrein.
Between 2014 and 2021, his most popular works were:
- Cancer immunotherapy: the beginning of the end of cancer? (511 citations)
- Cancer immunotherapy: the beginning of the end of cancer? (511 citations)
- Cancer immunotherapy: the beginning of the end of cancer? (511 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Internal medicine, Cancer, Proteomics, Oncology and Disease.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Immunology.
His Cancer research is multidisciplinary, incorporating perspectives in Blood test and Bioinformatics.
His research in Proteomics intersects with topics in Proteome, Tandem mass spectrometry, Proteases, Kallikrein and Computational biology.
The concepts of his Biomarker study are interwoven with issues in Cerebrospinal fluid and Pathology.
The various areas that Eleftherios P. Diamandis examines in his Pathology study include Prostate-specific antigen and Prostate cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
